- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Napsin A as a marker of clear cell ovarian carcinoma ; volume:13 ; number:1 ; day:5 ; month:11 ; year:2013 ; pages:1-12 ; date:12.2013
BMC cancer ; 13, Heft 1 (5.11.2013), 1-12, 12.2013
- Urheber
-
Skirnisdottir, Ingiridur
- Beteiligte Personen und Organisationen
-
Bjersand, Kathrine
Åkerud, Helena
Seidal, Tomas
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-524
- URN
-
urn:nbn:de:1111-201603048144
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Skirnisdottir, Ingiridur
- Bjersand, Kathrine
- Åkerud, Helena
- Seidal, Tomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
SOX17 expression in ovarian clear cell carcinoma
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
Significance of haemostatic markers in ovarian carcinoma
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
Cathepsin B-Like Activity as a Serum Tumour Marker in Ovarian Carcinoma
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
SOX17 expression in ovarian clear cell carcinoma
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
Significance of haemostatic markers in ovarian carcinoma
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
Cathepsin B-Like Activity as a Serum Tumour Marker in Ovarian Carcinoma
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
SOX17 expression in ovarian clear cell carcinoma
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
Significance of haemostatic markers in ovarian carcinoma
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
Cathepsin B-Like Activity as a Serum Tumour Marker in Ovarian Carcinoma
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus